{"title":"研究布洛芬和恩格列净在水相深度共晶溶剂体系中的溶解:实验和热力学模型的见解。","authors":"Shadi Janfaza, Ali Haghtalab","doi":"10.1007/s11095-025-03921-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study investigated the potential of a deep eutectic solvent (DES) to enhance the dissolution of two poorly water-soluble drugs, ibuprofen (IBU) and empagliflozin (EMPA). The DES was synthesized from tetrabutylphosphonium bromide (TBPB) and diethylene glycol (DEG).</p><p><strong>Methods: </strong>The apparent solubility of IBU and EMPA was measured in aqueous solutions containing eleven different mass fractions of the DES at temperatures ranging from 20 to 40°C. Dissolution kinetics were monitored over 24 h to differentiate between true equilibrium solubility and supersaturated states. The collected experimental data were then analyzed and correlated using three thermodynamic models: Wilson, NRTL, and UNIQUAC.</p><p><strong>Results: </strong>The findings indicated that ibuprofen achieved higher dissolution than empagliflozin in the DES-water system. For both drugs, the dissolution process was endothermic, with solubility increasing as both temperature and DES concentration increased. Among the thermodynamic models tested, the UNIQUAC model provided the most accurate correlation with the experimental dissolution data.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":"1647-1660"},"PeriodicalIF":4.3000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Investigating the Dissolution of Ibuprofen and Empagliflozin in Aqueous Deep Eutectic Solvent Systems: Experimental and Thermodynamic Modeling Insights.\",\"authors\":\"Shadi Janfaza, Ali Haghtalab\",\"doi\":\"10.1007/s11095-025-03921-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study investigated the potential of a deep eutectic solvent (DES) to enhance the dissolution of two poorly water-soluble drugs, ibuprofen (IBU) and empagliflozin (EMPA). The DES was synthesized from tetrabutylphosphonium bromide (TBPB) and diethylene glycol (DEG).</p><p><strong>Methods: </strong>The apparent solubility of IBU and EMPA was measured in aqueous solutions containing eleven different mass fractions of the DES at temperatures ranging from 20 to 40°C. Dissolution kinetics were monitored over 24 h to differentiate between true equilibrium solubility and supersaturated states. The collected experimental data were then analyzed and correlated using three thermodynamic models: Wilson, NRTL, and UNIQUAC.</p><p><strong>Results: </strong>The findings indicated that ibuprofen achieved higher dissolution than empagliflozin in the DES-water system. For both drugs, the dissolution process was endothermic, with solubility increasing as both temperature and DES concentration increased. Among the thermodynamic models tested, the UNIQUAC model provided the most accurate correlation with the experimental dissolution data.</p>\",\"PeriodicalId\":20027,\"journal\":{\"name\":\"Pharmaceutical Research\",\"volume\":\" \",\"pages\":\"1647-1660\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11095-025-03921-4\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11095-025-03921-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Investigating the Dissolution of Ibuprofen and Empagliflozin in Aqueous Deep Eutectic Solvent Systems: Experimental and Thermodynamic Modeling Insights.
Purpose: This study investigated the potential of a deep eutectic solvent (DES) to enhance the dissolution of two poorly water-soluble drugs, ibuprofen (IBU) and empagliflozin (EMPA). The DES was synthesized from tetrabutylphosphonium bromide (TBPB) and diethylene glycol (DEG).
Methods: The apparent solubility of IBU and EMPA was measured in aqueous solutions containing eleven different mass fractions of the DES at temperatures ranging from 20 to 40°C. Dissolution kinetics were monitored over 24 h to differentiate between true equilibrium solubility and supersaturated states. The collected experimental data were then analyzed and correlated using three thermodynamic models: Wilson, NRTL, and UNIQUAC.
Results: The findings indicated that ibuprofen achieved higher dissolution than empagliflozin in the DES-water system. For both drugs, the dissolution process was endothermic, with solubility increasing as both temperature and DES concentration increased. Among the thermodynamic models tested, the UNIQUAC model provided the most accurate correlation with the experimental dissolution data.
期刊介绍:
Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation. Current areas of interest include, but are not limited to:
-(pre)formulation engineering and processing-
computational biopharmaceutics-
drug delivery and targeting-
molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology)-
pharmacokinetics, pharmacodynamics and pharmacogenetics.
Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches. Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.